Our study has shown that FAS expression is significantly inhibited by EAOT administration, also suggesting that EAOTs’ anti-obesity effects are partly due to the inhibition of expression of fatty acid and TG synthesis-related proteins. This evidence concerns the gene FAS and obesity due to melanocortin 4 receptor deficiency.